Johnson & Johnson’s FDA-Approved Bladder Cancer Drug Offers New Option For Patients Avoiding Surgery

All NewsSeptember 11, 2025

The FDA approved Johnson & Johnson’s Inlexzo, offering a new bladder cancer treatment option with high response rates for patients, avoiding surgery.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent